Cameroon vs Equatorial Guinea: Hepatitis B surface antigen (HBsAg) prevalence
Cameroon
1.8%
in 2024
Equatorial Guinea
2.0%
in 2024
Cameroon rank
13th
Equatorial Guinea rank
12th
Hepatitis B surface antigen (HBsAg) prevalence over time
- Cameroon
- Equatorial Guinea
How they compare
Equatorial Guinea currently reports 2.0% against 1.8% in Cameroon, a difference of 0.2%.
That makes Equatorial Guinea's figure about 1.1 times Cameroon's.
Across all 10 years both countries report, Equatorial Guinea has been ahead every year.
Cameroon ranks 13th and Equatorial Guinea ranks 12th of 194 countries.
Equatorial Guinea has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Cameroon | Equatorial Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.0% | 2.3% | 0.3% | Equatorial Guinea |
| 2020s | 2.0% | 2.1% | 0.1% | Equatorial Guinea |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hepatitis b surface antigen (hbsag) prevalence, Cameroon or Equatorial Guinea?
- Equatorial Guinea, at 2.0% against 1.8% in Cameroon as of 2024.
- What is the difference in hepatitis b surface antigen (hbsag) prevalence between Cameroon and Equatorial Guinea?
- 0.2%, with Equatorial Guinea ahead.
- How many years of comparable data are there for Cameroon and Equatorial Guinea?
- 10 years are reported by both, from 2015 to 2024.
- How do Cameroon and Equatorial Guinea rank globally for hepatitis b surface antigen (hbsag) prevalence?
- Cameroon ranks 13th and Equatorial Guinea ranks 12th of 194 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Hepatitis B surface antigen (HBsAg) prevalence (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.